Sarep­ta li­cens­es next-gen AAV tech from Broad In­sti­tute in deal cov­er­ing five in­di­ca­tions — in­clud­ing Duchenne

3 years ago
Deals

Pfiz­er and My­ovant’s en­dometrio­sis pain drug Myfem­bree gets an­oth­er FDA nod

3 years ago
Pharma
FDA+

Clo­vis says it needs mon­ey af­ter re­verse split vot­ed down; Cin­Cor touts PhII da­ta for hy­per­ten­sion drug

3 years ago
News Briefing

Rea­ta con­tin­ues to hit FDA road­blocks with its Friedre­ich’s atax­ia can­di­date, not­ing reg­u­la­tor 'con­cern­s'

3 years ago
R&D
Pharma

Karuna's schiz­o­phre­nia drug pass­es a close­ly-watched PhI­II test, will head to FDA in mid-2023

3 years ago
R&D

Eli Lil­ly eyes growth out­side In­di­ana in wake of new abor­tion law — and New Jer­sey is ready

3 years ago
People
Pharma

Up­dat­ed: Pfiz­er scoops up Glob­al Blood Ther­a­peu­tics and its sick­le cell ther­a­pies for $5.4B

3 years ago
Deals

As­traZeneca push­es for­ward with Tagris­so com­bos, tout­ing PhII da­ta with Hutchmed drug

3 years ago
R&D
Pharma

Sen­ate Dems cling to a sim­ple ma­jor­i­ty to pass some of the biggest drug pric­ing re­forms ever

3 years ago
Pharma
Law

In a fresh dis­ap­point­ment, Am­gen spot­lights a ma­jor safe­ty is­sue with KRAS com­bo

3 years ago
R&D
Pharma

A $5B Pfiz­er buy­out? Am­gen, Gilead head­line M&A Thurs­day; Al­ny­lam's AT­TR sweep; An­drew Lo's rare dis­ease quest; and ...

3 years ago
Weekly

US de­clares mon­key­pox a na­tion­al health emer­gency, as new drug­mak­ers con­sid­er en­ter­ing vac­cine race

3 years ago
R&D
Pharma

Bio­haven touts surge in Nurtec sales ahead of Pfiz­er takeover

3 years ago
Pharma

AARP push­es for Medicare ne­go­ti­a­tions in TV ad as Con­gress tees up drug pric­ing leg­is­la­tion vote

3 years ago
Pharma
Marketing

Phar­ma brands chill in the phar­ma­cy re­tail aisle with new style ads on re­frig­er­a­tion screens

3 years ago
Pharma
Marketing

De­moc­rats se­cure sup­port from key sen­a­tor ahead of po­ten­tial drug pric­ing vote

3 years ago
Pharma
FDA+

Break­ing: Pfiz­er in hot pur­suit of a $5B buy­out of Glob­al Blood Ther­a­peu­tics — re­port

3 years ago
Deals

Gen­mab and BioN­Tech to col­lab­o­rate on new can­cer can­di­date; Small Aus­tralian biotech sees hope in brain metas­tases ...

3 years ago
News Briefing

Two years af­ter step­ping down amidst house ar­rest, Frank Zhang is back as Leg­end chair

3 years ago
People

Al San­drock prunes his post-Bio­gen voy­age with sim­i­lar fo­cus on ALS

3 years ago
R&D
Cell/Gene Tx

While Prax­is moves for­ward, Neu­ro­crine drops its es­sen­tial tremor drug

3 years ago
R&D

Aca­dia hits an­oth­er Nu­plazid road­block as the FDA doles out CRL and rec­om­mends an­oth­er tri­al

3 years ago
Pharma
FDA+

Ake­bi­a's ane­mia drug flunked Covid study — but count the bruised biotech 'ex­treme­ly en­cour­aged'

3 years ago
R&D
Coronavirus

Am­gen diss­es drug pric­ing bill, while amp­ing $4B rare drug com­pa­ny deal and up­com­ing Hu­mi­ra biosim launch

3 years ago
Pharma
Marketing
First page Previous page 483484485486487488489 Next page Last page
A service from the Financial Times